CYTK FY 2023 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M-92.0% YoY

Gross Profit

-$323M-4284.1% margin

Operating Income

-$496M-6589.7% margin

Net Income

-$526M-6988.6% margin

EPS (Diluted)

$-5.45

Cash Flow

Operating Cash Flow

-$414M

Free Cash Flow

-$416M

Stock-Based Comp.

$72M

Balance Sheet

Total Assets

$824M

Total Liabilities

$1.2B

Stockholders' Equity

-$386M

Cash & Equivalents

$113M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$95M	-92.0%
Gross Profit	-$323M	-$146M	-120.6%
Operating Income	-$496M	-$324M	-53.1%
Net Income	-$526M	-$389M	-35.3%